Tension cost correlates with mechanical and biochemical parameters in different myocardial contractility conditions

Clinics

Volumn 67, Issue 5, 2012, Pages 489-496

  Moreira, Cleci M ^a   Meira, Eduardo F ^b   Vestena, Luis ^a   Stefanon, Ivanita ^b,c   Vassallo, Dalton V ^b   Padilha, Alessandra S ^b  

^a UNIVERSIDADE FEDERAL DO PAMPA   (Brazil)

^b FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^c Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria   (Brazil)

Author keywords

Diabetes; Hypertension; Myocardial infarction; Myosin ATPase; Papillary muscles

Indexed keywords

DEOXYCORTICOSTERONE; DEOXYCORTICOSTERONE ACETATE; DRUG DERIVATIVE; ENZYME INHIBITOR; N(G) NITROARGININE METHYL ESTER; VENTRICULAR MYOSIN;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; HEART CONTRACTION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART PAPILLARY MUSCLE; HYPERTENSION; MALE; METABOLISM; NEPHRECTOMY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT;

ANIMALS; DESOXYCORTICOSTERONE; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; HYPERTENSION; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; NEPHRECTOMY; NG-NITROARGININE METHYL ESTER; PAPILLARY MUSCLES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; VENTRICULAR FUNCTION, LEFT; VENTRICULAR MYOSINS;

EID: 84863926287     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2012(05)14     Document Type: Article

References (39)

1. Barany K. ATPase activity of myosin correlated with speed of muscle shortening. J Gen Physiol. 1967;50(2):197-216, http://dx.doi.org/10.1085/jgp.50.6.197.
2. Botinelli R, Canepari M, Cappelli V, Reggiani C. Maximum speed of shortening and ATPase activity in atrial and ventricular myocardia of hyperthyroid rats. Am J Physiol. 1995;269:(3 Pt 1):C785-90.
3. Dhalla NS, Liu X, Panaglia V, Takeda N. Subcellular remodeling and heart dysfunction in chronic diabetes. Cardiovasc Res. 1998;40(2):239-47, http://dx.doi.org/10.1016/S0008-6363(98)00186-2.
4. Gupta MP. Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure. J Mol Cell Cardiol. 2007;43(4):388-403. Epub 2007 Jul 21, http://dx.doi.org/10.1016/j.yjmcc.2007.07.045
5. Mercadier JJ, Lompré AM, Wisnewsky C, Samuel JL, Bercovici J, Swynghedauw B, et al. Myosin isoenzymic changes in several models of rat cardiac hypertrophy. Circ Res. 1981;49(2):525-32.
6. Geenen DL, Malhotra A, Scheuer J. Regional variation in rat cardiac myosin isoenzymes and ATPase activity after infarction. Am J Physiol. 1989;256(3 Pt 2):H745-50.
7. ?-nitro-L-arginine methyl ester (L-NAME) hypertension. Cardiovasc Res. 2003;57(1):158-67, http://dx.doi.org/10.1016/S0008-6363(02)00654-5.
8. Stephens NL, Swynghedauw B. Cardiovascular adaptations to mechanical overload. Mol Cel Biochem. 1990;93(1):1-6.
9. Wang J, Liu X, Ren B, Rupp H, Takeda N, Dhalla NS. Modification of myosin gene expression by imidapril in failing heart due to myocardial infarction. J Mol Cell Cardiol. 2002;34(7):847-57, http://dx.doi.org/10.1006/jmcc.2002.2023.
10. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev. 1999;79(1):215-62.
11. Padilha AS, Moreira CM, Meira EF, Siman FD, Stefanon I, Vassallo DV. Chronic ouabain treatment enhances cardiac myosin ATPase activity in rats. Clin Exp Pharmacol Physiol. 2008;35(7):801-6, http://dx.doi.org/10.1111/j.1440-1681.2008.04916.x.
12. Fein FS, Zola BE, Malhotra A, Cho S, Factor SM, Scheuer J, et al. Hypertensive-diabetic cardiomyopathy in rats. Am J Physiol. 1990;258(3 Pt 2):H793-805.
13. 2+ pump ATPase and myosin isoenzymes can be prevented by sucrose. Biochem Biophys Res Commun. 1989;164(1):319-25, http://dx.doi.org/10.1016/0006-291X(89)91720-8.
14. G-Nitro-L-Arginine methyl Ester-induced Hypertension. Novel Molecular Adaptation to Systolic Load in Absence of Hypertrophy. Circulation. 2000;101(4):423-9.
15. Brenner B. Effect of Ca2+ on cross-bridge turnover kinetics in skinned single rabbit psoas fibers: implications for regulation of muscle contraction. Proc Natl Acad Sci U S A. 1988;85(9):3265-9, http://dx.doi.org/10.1073/pnas.85.9.3265.
16. Saeki Y. Crossbridge dynamics under various inotropic states in cardiac muscle: evaluation by perturbation analyses. Jpn J Physiol. 1995;45(5):687-705, http://dx.doi.org/10.2170/jjphysiol.45.687.
17. Rundell VLM, Geenen DL, Buttrick PM, Tombe PP. Depressed cardiac tension cost in experimental diabetes is due to altered myosin heavy chain isoform expression. Am J Physiol Heart Circ Physiol. 2004;287(1):H408-H413, http://dx.doi.org/10.1152/ajpheart.00049.2004.
18. Vassallo DV, Vasquez EC, Cabral AM. Contractile performance of papillary muscles of renovascular hypertensive and isoproterenolpretreated rats. Pharmacol Res Comm. 1988;20(1):61-72, http://dx.doi. org/10.1016/S0031-6989(88)80607-6.
19. Mill JG, Leite CM, Vassallo DV. Right ventricular contractility depression in chronically infarcted rats. Braz J Med Biol Res. 1988;21(3):621-4.
20. Leite CM, Mill JG, Vassallo DV. Characteristics of tetanic contractions in the caffeine treated rat myocardium. Can J Physiol Pharmacol. 1995;73(5):638-43, http://dx.doi.org/10.1139/y95-081.
21. 2+-ATPase activity. Anal Biochem 1986;157(2):375-80.
22. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:218-54, http://dx.doi.org/10.1016/0003-2697(76)90527-3.
23. Mill JG, Novaes MAS, Galon M, Nogueira JB, Vassallo DV. Comparison of the contractile performance of the hypertrophied myocardium from spontaneous hypertensive rats and normotensive infarcted rats. Can J Physiol Pharmacol. 1998;76(4):387-394, http://dx.doi.org/10.1139/y98-013.
24. Novaes MAS, Stefanon I, Mill JG, Vassallo DV. Contractility changes of the right and left ventricular muscle after chronic myocardial infaction. Braz J Med Biol Res. 1996;29(12):1683-90.
25. Pereira RB, Sartório CL, Vassallo DV, Stefanon I. Differences in tail vascular bed reactivity in rats with and without heart failure following myocardial infarction. J Pharmacol Exp Ther. 2005; 312(3):1321-5.
26. Min J-Y, Ding B, Wang J-F, Sullivan MF, Morgan JP. Metoprolol attenuates postischemic depressed myocardial function in papillary muscles isolated from normal and postinfarction rat hearts. Eur J Pharmacol. 2001;422(1-3):115-25, http://dx.doi.org/10.1016/S0014-2999(01)01050-0.
27. Geenen DL, White TP, Lampman RM. Papillary mechanics and cardiac morphology of infarcted rat hearts after training. J Appl Physiol. 1987;63(1):92-6.
28. Lefroy DC, Crake T, Del Monte F, Vescovo G, Dalla Libera L, Harding S, et al. Angiotensin II and contraction of isolated myocytes from human, guinea pig, and infarcted rat hearts. Am J Physiol. 1996;270(6 Pt 2)H2060-9.
29. Manso AM, Encabo A, Ferrer M, Balfagón G, Salaices M, Marín J. Changes of cardiac calcium homeostasis in spontaneously hypertensive rats. J Auton Pharmacol. 1999;19(2):123-30, http://dx.doi.org/10.1046/j.1365-2680.1999.00127.x.
30. Shorofsky SR, Aggarwal R, Corretti M, Baffa JM, Strum JM, Al-Seikhan BA, et al. Cellular mechanisms of altered contractility in the hypertrophied heart: big hearts, big sparks. Circ Res. 1999;84(4):424-34.
31. Bokník P, Heinroth-Hoffmann I, Kirchhefer U, Knapp J, Linck B, Lüss H, et al. Enhanced protein phosphorylation in hypertensive hypertrophy. Cardiovasc Res. 2001;51(4):717-28, http://dx.doi.org/10.1016/S0008-6363(01)00346-7.
32. Morano I, Gagelmann M, Arner A, Ganten U, Rüegg JC. Myosin isoenzymes of vascular smooth and cardiac muscle in the spontaneously hypertensive and normotensive male and female rat: a comparative study. Circ Res. 1986;59(4):456-62.
33. Brooks WW, Bing OH, Boluyt MO, Malhotra A, Morgan JP, Satoh N, et al. Altered inotropic responsiveness and gene expression of hypertrophied myocardium with captopril. Hypertension. 2000;35(6):1203-9.
34. McCullought AL, McNeill JH. Chronic diabetes decreases the ouabain inotropic response in rat left atria and papillary muscles. Gen Pharmacol. 1983;14(4):401-5.
35. Morris GS, Prevost MC, Nelson AG. Moderate diabetes alters myosin isoenzyme distribution in cardiac but not skeletal muscle of male rats. Life Sci. 1996;58(10):833-8, http://dx.doi.org/10.1016/0024-3205(96)00016-1.
36. Pedroni P, Perez GN, Mattiazzi A. Calcium sensitivity of isometric tension in intact papillary muscles and chemically skinned trabeculae in different models of hypertensive hypertrophy. Cardiovasc Res. 1990;24(7):584-90, http://dx.doi.org/10.1093/cvr/24.7.584.
37. Besse S, Assayag P, Delcayre C, Carre F, Cheav SL, Lecarpentier Y, et al. Normal and hypertrophied senescent rat heart: mechanical and molecular characteristics. Am J Physiol. 1993;265(1 Pt 2):H183-90.
38. Takaori K, Kim S, Ohta K, Hamaguchi A, Yagi K, Iwao H. Inhibition of nitric oxide synthase causes cardiac phenotypic modulation in rat. Eur J Pharmacol. 1997;322(1):59-62, http://dx.doi.org/10.1016/S0014-2999(97)00058-7.
39. Oliveira CF, Cintra KA, Teixeira SA, De Luca IMS, Antunes E, De Nucci G. Development of cardiomyocyte hypotrophy in rats under prolonged treatment with a low dose of a nitric oxide synthesis inhibitor. Eur J Pharmacol. 2000;391(1-2):121-6, http://dx.doi.org/10.1016/S0014-2999(99)00929-2.